Rheumatic fever and rheumatic heart disease

Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult: Eighth Edition

Volumn 2-2, Issue , 2013, Pages

  Tani, Lloyd Y ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974777480     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (203)

1. Steer AC, Carapetis JR, Nolan TM, et al. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002;38:229-234.
2. Agarwal BL. Rheumatic heart disease unabated in developing countries. Lancet 1981;2:910-911.
3. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 2001;80:213-219.
4. Olivier C. Rheumatic fever-is it still a problem? J Antimicrob Chemother 2000;45:13-21.
5. Ibrahim A, Rahman AR. Rheumatic heart disease: how big is the problem? Med J Malaysia 1995;50:121-124.
6. Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ 1995;73:583-587.
7. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004;923:1-122, back cover.
8. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-694.
9. Carapetis JR, Currie BJ, Mathews JD. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 2000;124:239-244.
10. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155-168.
11. Massell BF, Chute CG, Walker AM, et al. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988;318:280-286.
12. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985;72:1155-1162.
13. Shulman ST, Stollerman G, Beall B, et al. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 2006;42:441-447.
14. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. New Engl J Med 1987;316:421-427.
15. Hosier DM, Craenen JM, Teske DW, et al. Resurgence of acute rheumatic fever. Am J Dis Children 1987;141:730-733.
16. Congeni B, Rizzo C, Congeni J, et al. Outbreak of acute rheumatic fever in northeast Ohio. J Pediatr 1987;111:176-179.
17. Wald ER, Dashefsky B, Feidt C, et al. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 1987;80:371-374.
18. Westlake RM, Graham TP, Edwards KM. An outbreak of acute rheumatic fever in Tennessee. Pediatr Infect Dis J 1990;9:97-100.
19. Leggiadro RJ, Birnbaum SE, Chase NA, et al. A resurgence of acute rheumatic fever in a mid-South children's hospital. South Med J 1990;83:1418-1420.
20. Kavey RE, Kaplan EL. Resurgence of acute rheumatic fever. Pediatrics 1989;84:585-586.
21. Veasy LG, Tani LY, Daly JA, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004;113:e168-172.
22. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96:758-764.
23. Gerber MA, Markowitz M. Management of streptococcal pharyngitis reconsidered. Pediatr Infect Dis 1985;4:518-526.
24. Steer AC, Adams J, Carlin J, et al. Rheumatic heart disease in school children in Samoa. Arch Dis Child 1999;81:372.
25. Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009;120:663-668.
26. Barlow JB. Aspects of active rheumatic carditis. Aust N Z J Med 1992;22:592-600.
27. Marcus RH, Sareli P, Pocock WA, et al. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. [see comments.]. Ann Intern Med 1994;120:177-183.
28. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health 1999;23:159-163.
29. Roy SB, Bhatia ML, Lazaro EJ, et al. Juvenile mitral stenosis in India. Lancet 1963;41:1193-1195.
30. Joshi MK, Kandoth PW, Barve RJ, et al. Rheumatic fever. Clinical profile of 339 cases with long term follow up. Indian Pediatr 1983;20:849-853.
31. Oli K, Asmera J. Rheumatic heart disease in Ethiopia: could it be more malignant? Ethiop Med J 2004;42:1-8.
32. Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart 2000;83:721-725.
33. Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1988;764:1-58.
34. Gibofsky A, Kerwar S, Zabriskie JB. Rheumatic fever. The relationships between host, microbe, and genetics. Rheum Dis Clin North Am 1998;24:237-259.
35. Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 2007;120:503-508.
36. Kumar RK, Rammohan R, Narula J, et al. Epidemiology of streptococcal pharyngitis, rheumatic fever, and rheumatic heart disease. In: Narula J, Virmani R, Reddy KS, et al., eds. Rheumatic Fever. Washington, DC: American Registry of Pathology, 1999:41-68.
37. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-793.
38. Tani LY, Veasy LG, Minich LL, et al. Rheumatic fever in children younger than 5 years: is the presentation different? Pediatrics 2003;112:1065-1068.
39. Rosenthal A, Czoniczer G, Massell BF. Rheumatic fever under 3 years of age. A report of 10 cases. Pediatrics 1968;41:612-619.
40. McDanald EC, Weisman MH. Articular manifestations of rheumatic fever in adults. Ann Intern Med 1978;89:917-920.
41. Stollerman GH. Rheumatic fever. [see comments.]. Lancet 1997;349:935-942.
42. Bisno AL. Noncardiac manifestations of rheumatic fever. In: Narula J, Virmani R, Reddy KS, et al., eds. Rheumatic Fever. Washington, DC: American Registry of Pathology, 1999:245-256.
43. Nausieda PA, Grossman BJ, Koller WC, et al. Sydenham chorea: an update. Neurology 1980;30:331-334.
44. Feinstein AR, Spagnuolo M. The clinical patterns of acute rheumatic fever: a reappraisal. Medicine 1962;41:279-305.
45. Feinstein AR, Spagnuolo M, Wood HF, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. VI. Clinical features of streptococcal infections and rheumatic recurrences. Ann Intern Med 1964;60::68-86.
46. Rammelkamp CH. Epidemiology of streptococcal infections. Harvey Lect 1956;51:113-142.
47. Massell BF. Factors in the pathogenesis of rheumatic fever recurrences. J Maine Med Assoc 1962;53:88-93.
48. Wilson MG, Schweitzer MD, Rubshez R. The familial epidemiology of rheumatic fever. J Pediatr 1943;22:468-492.
49. Cheadle WB. The various manifestations of the rheumatic state as exemplified in childhood and early life. Lancet 1889;1:821-827.
50. DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980;99:635-658.
51. Taranta A, Torosdag S, Metrakos JD, et al. Rheumatic fever in monozygotic and dizygotic twins. Circulation 1959;20:778.
52. Ayoub EM. The search for host determinants of susceptibility to rheumatic fever: the missing link. T. Duckett Jones Memorial Lecture. Circulation 1984;69:197-201.
53. Chun LT, Reddy V, Rhoads GG. Occurrence and prevention of rheumatic fever among ethnic groups of Hawaii. Am J Dis Child 1984;138:476-478.
54. Kurahara D, Tokuda A, Grandinetti A, et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J Rheumatol 2002;29:379-383.
55. McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004;291:1587-1595.
56. Gieseker KE, Roe MH, MacKenzie T, et al. Evaluating the American Academy of Pediatrics diagnostic standard for Streptococcus pyogenes pharyngitis: backup culture versus repeat rapid antigen testing. Pediatrics 2003;111:e666-670.
57. Kaplan EL, Huew BB. The sensitivity and specificity of an agglutination test for antibodies to streptococcal extracellular antigens: a quantitative analysis and comparison of the streptozyme test with the anti-streptolysin O and anti-deoxyribonuclease B tests. J Pediatr 1980;96:367-373.
58. Martin JM, Green M, Barbadora KA, et al. Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics 2004;114:1212-1219.
59. Pichichero ME, Marsocci SM, Murphy ML, et al. Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 1999;153:624-628.
60. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. [see comments.]. J Pediatr 1994;124:9-16.
61. Coburn AF, Pauli RH. Studies of the immune response of the rheumatic subject and its relationship to activity of the rheumatic process. IV. Characteristics of strains of hemolytic streptococcus, effective and non-effective in initiating rheumatic activity. J Clin Invest 1935;14:755-762.
62. Bisno AL, Pearce IA, Stollerman GH. Streptococcal infections that fail to cause recurrences of rheumatic fever. J Infect Dis 1977;136:278-285.
63. Stollerman GH. Nephritogenic and rheumatogenic group A streptococci. J Infect Dis 1969;120:258-263.
64. Stollerman GH. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts of Cardiovasc Dis 1975;44:35-40.
65. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470-511.
66. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001;33:806-814.
67. Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991;61:131-142.
68. Stollerman GH. Rheumatogenic group A streptococci and the return of rheumatic fever. Adv Intern Med 1990;35:1-25.
69. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992;166:374-382.
70. Smoot JC, Korgenski EK, Daly JA, et al. Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002;40:1805-1810.
71. Miner LJ, Petheram SJ, Daly JA, et al. Molecular characterization of Streptococcus pyogenes isolates collected during periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J 2004;23:56-61.
72. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet 1996;347:1271-1272.
73. McDonald MI, Towers RJ, Andrews RM, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006;43:683-689.
74. Kaplan EL, Bisno AL. Antecedent streptococcal infection in acute rheumatic fever. Clin Infect Dis 2006;43:690-692.
75. Stollerman GH, Lewis AJ, Schultz I, et al. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956;20:163-169.
76. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951;10:673-695.
77. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. JAMA 1950;143:151-153.
78. Massell BF. Management of rheumatic fever; therapy of the acute attack and prevention of recurrences. Pediatr Clin North Am 1958;5:1143-1159.
79. Massell BF, Dow JF, Jones TD. Orally administered penicillin in patient with rheumatic fever. JAMA 1948;138:1030-1036.
80. Thomas CB, France R. Preliminary report of prophylactic use of sulfanilamide in patients susceptible to rheumatic fever. Bull Johns Hopkins Hosp 1939;64:67-77.
81. Frank PF, Stollerman GH, Miller LF. Protection of a military population from rheumatic fever. Routine administration of Benzathine Penicillin G to healthy individuals. JAMA 1965;193:775-783.
82. Ottolini MG, Burnett MW. History of U.S. military contributions to the study of respiratory infections. Mil Med. 2005;170:66-70.
83. Acute rheumatic fever among Army trainees-Fort Leonard Wood, Missouri, 1987-1988. MMWR Morb Mortal Wkly Rep 1988;37:519-522.
84. Rammelkamp CH Jr, Stolzer BL. The latent period before the onset of acute rheumatic fever. Yale J Biol Med 1961;34:386-398.
85. Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 1991;12:55-60.
86. Ayoub EM, Barrett DJ, Maclaren NK, et al. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986;77:2019-2026.
87. Guedez Y, Kotby A, El-Demellawy M, et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999;99:2784-2790.
88. Gerbase-DeLima M, Scala LC, Temin J, et al. Rheumatic fever and the HLA complex. A cosegregation study. Circulation 1994;89:138-141.
89. Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004;165:1583-1591.
90. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010;30:17-23.
91. Khanna AK, Buskirk DR, Williams RC Jr, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989;83:1710-1716.
92. Zabriskie JB, Lavenchy D, Williams RC Jr, et al. Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum 1985;28:1047-1051.
93. Weisz JL, McMahon WM, Moore JC, et al. D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette's disorder. Clin Diagn Lab Immunol 2004;11:330-336.
94. Bryant PA, Robins-Browne R, Carapetis JR, et al. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 2009;119:742-753.
95. Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 2003;21:59-63.
96. Chou HT, Tsai CH, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 2004;45:949-957.
97. Davutoglu V, Nacak M. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. J Heart Valve Dis 2005;14:277-281.
98. Kaplan MH, Meyeserian M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet 1962;1:706-710.
99. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985;162:583-591.
100. Cunningham MW, McCormack JM, Talaber LR, et al. Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol 1988;141:2760-2766.
101. Zabriskie JB, Hsu KC, Seegal BC. Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol 1970;7:147-159.
102. Roberts S, Kosanke S, Terrence Dunn S, et al. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 2001;183:507-511.
103. Ellis NM, Li Y, Hildebrand W, et al. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 2005;175:5448-5456.
104. Guilherme L, Kalil J, Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006;39:31-39.
105. Carreno-Manjarrez R, Visvanathan K, Zabriskie JB. Immunogenic and genetic factors in rheumatic fever. Curr Infect Dis Rep 2000;2:302-307.
106. Cunningham MW. Molecular mimicry between group A streptococci and myosin in the pathogenesis of acute rheumatic fever. In: Narula J, Virmani R, Reddy KS, et al., eds. Rheumatic Fever. Washington, DC: American Registry of Pathology, 1999:135-165.
107. Guilherme L, Fae KC, Oshiro SE, et al. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann N Y Acad Sci 2005;1051:132-140.
108. Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006;176:5662-5670.
109. Steer AC, Carapetis JR. Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol 2009;6:689-698.
110. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease: a twenty year report on 1000 patients followed since childhood. Circulation 1951;4:836-843.
111. The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation 1965;32:457-476.
112. Feinstein AR, Stern EK, Spagnuolo M. The prognosis of acute rheumatic fever. Am Heart J 1964;68:817-834.
113. Sanyal S, Berry A, Duggal S, et al. Sequelae of the initial attack of acute rheumatic fever in children from North India. A prospective 5-year follow-up study. Circulation 1982;65:375-379.
114. Feinstein AR, Stern EK. Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. J Chronic Dis 1967;20:13-27.
115. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972;45:543-551.
116. Feinstein AR, Wood HF, Spagnuolo M, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. VII. Cardiac changes and sequelae. Ann Intern Med 1964;60::87-123.
117. The Evolution of Rheumatic Heart Disease in Children. Five-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation 1960;22:503-515.
118. Majeed HA, Batnager S, Yousof AM, et al. Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report. J Clin Epidemiol 1992;45:871-875.
119. Thomas GT. Five-year follow-up on patients with rheumatic fever treated by bed rest, steroids, or salicylate. Br Med J 1961;5240:1635-1639.
120. Gross L, Ehrlich JC. Studies on the myocardial Aschoff body. II. Life cycle, sites of predilection and relation to clinical course of rheumatic fever. Am J Pathol 1934;10:489-503.
121. Saphir O. The Aschoff nodule. Am J Clin Pathol 1959;31:534-539.
122. Virmani R, Roberts W. Aschoff bodies in operatively excised atrial appendages and in papillary muscles. Frequency and clinical significance. Circulation 1977;55:559-563.
123. Gross L, Fried BM. Lesions in the auriculoventricular conduction system occurring in rheumatic fever. Am J Pathol 1936;12:31-43.
124. Virmani R, Farb A, Burke AP, et al. Pathology of acute rheumatic carditis. In: Narula J, Virmani R, Reddy KS, et al., eds. Rheumatic Fever. Washington, DC: American Registry of Pathology, 1999:217-234.
125. Gross L, Friedberg CK. Lesions of the cardiac valve rings in rheumatic fever. Am J Pathol 1935;12:469-493.
126. Camara EJ, Neubauer C, Camara GF, et al. Mechanisms of mitral valvar insufficiency in children and adolescents with severe rheumatic heart disease: an echocardiographic study with clinical and epidemiological correlations. Cardiol Young 2004;14:527-532.
127. Kamblock J, N'Guyen L, Pagis B, et al. Acute severe mitral regurgitation during first attacks of rheumatic fever: clinical spectrum, mechanisms and prognostic factors. J Heart Valve Dis 2005;14:440-446.
128. Tomaru T, Uchida Y, Mohri N, et al. Postinflammatory mitral and aortic valve prolapse: a clinical and pathological study. Circulation 1987;76:68-76.
129. Gross L, Kugel MA, Epstein EZ. Lesions of the coronary arteries and their branches in rheumatic fever. Am J Path 1935;11:253-279.
130. Jones TD. Diagnosis of rheumatic fever. JAMA 1944;126:481-484.
131. Anonymous. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 1965;32:664-668.
132. Anonymous. Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1984;69:204A-208A.
133. Anonymous. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. [See comments.] [Erratum appears in JAMA 1993;269(4):476.]. JAMA 1992;268:2069-2073.
134. Rutstein DD, Bauer, Dorfman A, et al. Jones Criteria (modified) for guidance in the diagnosis of rheumatic fever. Mod Concepts Cardiovasc Dis 1955;24:291-293.
135. Shiffman RN. Guideline maintenance and revision. 50 years of the Jones criteria for diagnosis of rheumatic fever. [See comments.]. Arch Pediatr Adolesc Med 1995;149:727-732.
136. Carapetis JR, Currie BJ. Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever. Arch Dis Child 2001;85:223-227.
137. Saxena A. Diagnosis of rheumatic fever: current status of Jones criteria and role of echocardiography. Indian J Pediatr 2000;67:S11-S14.
138. Ralph A, Jacups S, McGough K, et al. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia's Northern Territory. Heart Lung Circ2006;15:113-118.
139. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992;268:2069-2073.
140. Giannoulia-Karantana A, Anagnostopoulos G, Kostaridou S, et al. Childhood acute rheumatic fever in Greece: experience of the past 18 years. Acta Paediatr 2001;90:809-812.
141. Sanyal SK, Thapar MK, Ahmed SH, et al. The initial attack of acute rheumatic fever during childhood in North India; a prospective study of the clinical profile. Circulation 1974;49:7-12.
142. Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch Med Res 2003;34:382-387.
143. Bitar FF, Hayek P, Obeid M, et al. Rheumatic fever in children: a 15-year experience in a developing country. Pediatr Cardiol 2000;21:119-122.
144. Arora R, Subramanyam G, Khalilullah M, et al. Clinical profile of rheumatic fever and rheumatic heart disease: a study of 2,500 cases. Indian Heart J 1981;33:264-269.
145. Chagani HS, Aziz K. Clinical profile of acute rheumatic fever in Pakistan. Cardiol Young 2003;13:28-35.
146. Chockalingam A, Gnanavelu G, Elangovan S, et al. Current profile of acute rheumatic fever and valvulitis in southern India. J Heart Valve Dis 2003;12:573-576.
147. Griffiths SP, Gersony WM. Acute rheumatic fever in New York City (1969 to 1988): a comparative study of two decades. J Pediatr 1990;116:882-887.
148. Khriesat I, Najada A, Al-Hakim F, et al. Acute rheumatic fever in Jordanian children. East Mediterr Health J 2003;9:981-987.
149. Steer AC, Kado J, Jenney AW, et al. Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007. Med J Aust 2009;190:133-135.
150. Cann MP, Sive AA, Norton RE, et al. Clinical presentation of rheumatic fever in an endemic area. Arch Dis Child 95:455-457.
151. Carapetis JR, Brown A, Wilson NJ, et al. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust 2007;186:581-586.
152. Atatoa-Carr P, Lennon D, Wilson N. Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J 2008;121:59-69.
153. Olgunturk R, Canter B, Tunaoglu FS, et al. Review of 609 patients with rheumatic fever in terms of revised and updated Jones criteria. Int J Cardiol 2006;112:91-98.
154. Carapetis JR, Currie BJ. Rheumatic chorea in Northern Australia: a clinical and epidemiological study. Arch Dis Child 1999;80:353-358.
155. Denny FW. T. Duckett Jones and rheumatic fever in 1986. T. Duckett Jones Memorial Lecture. Circulation 1987;76:963-970.
156. Feinstein AR, Spagnuolo M, Gill FA. The rebound phenomenon in acute rheumatic fever. I. Incidence and significance. Yale J Biol Med 1961;33:259-278.
157. Hilario MO, Terreri MT. Rheumatic fever and post-streptococcal arthritis. Best Pract Res Clin Rheumatol 2002;16:481-494.
158. Pinals RS. Polyarthritis and fever. N Engl J Med 1994;330:769-774.
159. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 2004;43:949-954.
160. Shulman ST, Ayoub EM. Poststreptococcal reactive arthritis. Curr Opin Rheumatol. 2002;14:562-565.
161. De Cunto CL, Giannini EH, Fink CW, et al. Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J 1988;7:683-686.
162. Ahmed S, Ayoub EM, Scornik JC, et al. Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 1998;41:1096-1102.
163. van Bemmel JM, Delgado V, Holman ER, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum 2009;60:987-993.
164. Ayoub EM, Majeed HA. Poststreptococcal reactive arthritis. Curr Opin Rheumatol 2000;12:306-310.
165. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009;119:1541-1551.
166. van der Helm-van Mil AH. Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Curr Opin Rheumatol 22:437-442.
167. Buchanan DN. Pathologic changes in chorea. Am J Dis Child 1941;62:443-445.
168. Aron AM, Freeman JM, Carter S. The natural history of Sydenham's Chorea. Review of the literature and long-term evaluation with emphasis on cardiac sequelae. Am J Med 1965;38:83-95.
169. Goldenberg J, Ferraz MB, Fonseca AS, et al. Sydenham chorea: clinical and laboratory findings. Analysis of 187 cases. Rev Paul Med 1992;110:152-157.
170. Lessof MH, Bywaters EG. The duration of chorea. Br Med J 1956:1520-1523.
171. Berrios X, Quesney F, Morales A, et al. Are all recurrences of "pure" Sydenham chorea true recurrences of acute rheumatic fever? J Pediatr 1985;107:867-872.
172. Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994;272:1788-1791.
173. Burge DJ, DeHoratius RJ. Acute rheumatic fever. Cardiovasc Clin 1993;23:3-23.
174. Eshel G, Lahat E, Azizi E, et al. Chorea as a manifestation of rheumatic fever-a 30-year survey (1960-1990). Eur J Pediatr 1993;152:645-646.
175. Bland EF. Chorea as a manifestation of rheumatic fever: a long-term perspective. Trans Am Clin Climatol Assoc 1961;73:209-213.
176. Zomorrodi A, Wald ER. Sydenham's chorea in western Pennsylvania. Pediatrics 2006;117:e675-e679.
177. Heye N, Jergas M, Hotzinger H, et al. Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol 1993;240:121-123.
178. Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993;91:706-713.
179. Murphy TK, Goodman WK, Ayoub EM, et al. On defining Sydenham's chorea: where do we draw the line? Biol Psychiatry 2000;47:851-857.
180. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
181. Garvey MA, Giedd J, Swedo SE. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol 1998;13:413-423.
182. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354:1153-1158.
183. Kurlan R, Johnson D, Kaplan EL. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008;121:1188-1197.
184. Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr 2009;21:127-130.
185. Massell BF. The diagnosis and treatment of rheumatic fever and rheumatic carditis. Med Clin North Am 1958;42:1343-1360.
186. Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989;63:577-584.
187. Barlow JB, Marcus RH, Pocock WA, et al. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J 1990;78:181-186.
188. Zhou LY, Lu K. Inflammatory valvular prolapse produced by acute rheumatic carditis: echocardiographic analysis of 66 cases of acute rheumatic carditis. Int J Cardiol 1997;58:175-178.
189. de Moor MM, Lachman PI, Human DG. Rupture of tendinous chords during acute rheumatic carditis in young children. Int J Cardiol 1986;12:353-357.
190. Oliveira DB, Dawkins KD, Kay PH, et al. Chordal rupture. I: aetiology and natural history. Br Heart J 1983;50:312-317.
191. Kalangos A, Beghetti M, Vala D, et al. Anterior mitral leaflet prolapse as a primary cause of pure rheumatic mitral insufficiency. Ann Thorac Surg 2000;69:755-761.
192. Sutton GC, Craige E. Clinical signs of severe acute mitral regurgitation. Am J Cardiol 1967;20:141-144.
193. Coombs CF. Rheumatic Heart Disease. New York: William Woods, 1924.
194. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-1984.
195. Przybojewski JZ. Rheumatic constrictive pericarditis. A case report and review of the literature. S Afr Med J 1981;59:682-686.
196. Stollerman G. Rheumatic Fever and Streptococcal Infection. New York: Grune & Stratton, 1975:127-131.
197. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol 1993;22:826-829.
198. Narula J, Chopra P, Talwar KK, et al. Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis? Circulation 1993;88:2198-2205.
199. Kamblock J, Payot L, Iung B, et al. Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels. Eur Heart J 2003;24:855-862.
200. Williams RV, Minich LL, Shaddy RE, et al. Evidence for lack of myocardial injury in children with acute rheumatic carditis. Cardiol Young 2002;12:519-523.
201. Gentles TL, Colan SD, Wilson NJ, et al. Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol 2001;37:201-207.
202. Vasan RS, Shrivastava S, Vijayakumar M, et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996;94:73-82.
203. Vardi P, Markiewicz W, Weiss Y, et al. Clinical-echocardiographic correlations in acute rheumatic fever. Pediatrics 1983;71:830-834.